HK Stock MarketDetailed Quotes

GRAND PHARMA (00512)

Watchlist

7.810
-0.100-1.26%

Market Closed Jan 16 16:08 CST

27.72BMarket Cap13.33P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

GRAND PHARMA (00512) Income Statement

All

YOY

Hide blank lines

(Q6)Jun 30, 2025

(FY)Dec 31, 2024

(Q6)Jun 30, 2024

(FY)Dec 31, 2023

(Q6)Jun 30, 2023

(FY)Dec 31, 2022

(Q6)Jun 30, 2022

(FY)Dec 31, 2021

(Q6)Jun 30, 2021

(FY)Dec 31, 2020

Turnover

0.99%6.11B

10.59%11.64B

0.96%6.05B

10.12%10.53B

14.90%5.99B

11.22%9.56B

14.15%5.21B

35.34%8.6B

40.26%4.57B

-3.61%6.35B

Operating income

0.99%6.11B

10.59%11.64B

0.96%6.05B

10.12%10.53B

14.90%5.99B

11.22%9.56B

14.15%5.21B

35.34%8.6B

40.26%4.57B

-3.61%6.35B

Cost of sales

-2.09%-2.51B

-22.50%-4.91B

-15.79%-2.46B

-10.93%-4.01B

-8.63%-2.12B

-7.76%-3.61B

-16.66%-1.95B

-44.57%-3.35B

-37.73%-1.67B

9.08%-2.32B

Operating expenses

-2.09%-2.51B

-22.50%-4.91B

-15.79%-2.46B

-10.93%-4.01B

-8.63%-2.12B

-7.76%-3.61B

-16.66%-1.95B

-44.57%-3.35B

-37.73%-1.67B

9.08%-2.32B

Gross profit

0.25%3.6B

3.28%6.74B

-7.16%3.59B

9.62%6.52B

18.66%3.87B

13.42%5.95B

12.70%3.26B

30.04%5.25B

41.77%2.89B

-0.15%4.04B

Selling expenses

-18.88%-1.92B

-26.84%-3.26B

1.57%-1.61B

-11.32%-2.57B

-19.27%-1.64B

3.81%-2.31B

2.94%-1.37B

-28.91%-2.4B

-48.06%-1.41B

16.94%-1.86B

Administrative expenses

-14.11%-691.75M

-10.61%-1.37B

12.89%-606.2M

-13.24%-1.23B

-26.35%-695.89M

-19.83%-1.09B

-28.34%-550.76M

-32.74%-909.62M

-39.62%-429.15M

-12.40%-685.24M

Revaluation surplus

-60.66%174.59M

451.71%648.55M

93.22%443.75M

314.11%117.55M

158.50%229.66M

-111.52%-54.9M

-231.34%-392.56M

75.56%476.5M

5,081.53%298.89M

2,668.46%271.41M

-Changes in the fair value of derivative financial instruments

----

12.71%-27.38M

----

-178.98%-31.37M

----

575.69%39.72M

----

---8.35M

----

-Changes in the fair value of financial assets

-60.66%174.59M

353.88%675.93M

93.22%443.75M

257.38%148.92M

158.50%229.66M

-119.52%-94.62M

-231.34%-392.56M

78.64%484.85M

5,081.53%298.89M

2,668.46%271.41M

Impairment and provision

----

22.23%-122.45M

----

-1,072.83%-157.45M

---59.65M

-3,703.12%-13.43M

----

98.02%-353K

----

69.21%-17.81M

-Goodwill impairment

----

-25.39%-49.07M

----

-7.39%-39.14M

----

---36.44M

----

-Other impairment is provision

----

37.98%-73.38M

----

-614.04%-118.32M

---59.65M

6,620.40%23.02M

----

98.02%-353K

----

69.21%-17.81M

Special items of operating profit

147.42%203.58M

324.22%241.73M

131.75%82.28M

-150.96%-107.81M

-409.81%-259.14M

-39.38%211.57M

36.67%83.64M

-9.00%349.02M

-35.97%61.2M

45.47%383.55M

Operating profit

-27.85%1.37B

12.02%2.88B

31.36%1.9B

-4.59%2.57B

40.73%1.45B

-2.41%2.7B

-27.09%1.03B

29.99%2.76B

62.46%1.41B

53.30%2.13B

Financing cost

6.70%-80.35M

12.14%-180.24M

23.94%-86.12M

-49.20%-205.15M

-79.13%-113.23M

-47.90%-137.49M

-167.05%-63.21M

19.46%-92.96M

59.27%-23.67M

21.22%-115.42M

Share of profits of associates

207.95%57.94M

694.69%148.72M

376.26%18.82M

42.89%-25.01M

85.92%-6.81M

-138.46%-43.79M

-308.46%-48.38M

83.71%113.86M

-62.66%23.21M

-46.09%61.98M

Earning before tax

-26.42%1.35B

21.68%2.85B

38.18%1.83B

-6.86%2.34B

44.77%1.33B

-9.65%2.52B

-34.99%915.7M

34.35%2.79B

61.66%1.41B

52.92%2.07B

Tax

28.73%-174.02M

13.92%-386.3M

9.20%-244.18M

-7.19%-448.76M

-23.49%-268.93M

-9.94%-418.64M

-6.60%-217.78M

-30.24%-380.8M

-23.44%-204.3M

-26.85%-292.37M

After-tax profit from continuing operations

-26.07%1.17B

30.10%2.47B

50.24%1.59B

-9.67%1.9B

51.42%1.06B

-12.76%2.1B

-42.04%697.92M

35.02%2.41B

70.62%1.2B

58.26%1.78B

Earning after tax

-26.07%1.17B

30.10%2.47B

50.24%1.59B

-9.67%1.9B

51.42%1.06B

-12.76%2.1B

-42.04%697.92M

35.02%2.41B

70.62%1.2B

58.26%1.78B

Minority profit

-83.70%4.85M

-115.00%-2.32M

8.55%29.76M

-17.99%15.44M

319.55%27.42M

662.74%18.83M

-837.19%-12.49M

121.56%2.47M

113.35%1.69M

55.02%-11.45M

Profit attributable to shareholders

-24.96%1.17B

31.30%2.47B

51.35%1.56B

-9.59%1.88B

44.90%1.03B

-13.45%2.08B

-40.92%710.41M

34.02%2.4B

67.37%1.2B

55.76%1.79B

Basic earnings per share

-24.84%0.3338

31.51%0.7049

52.51%0.4441

-8.69%0.536

44.44%0.2912

-13.32%0.587

-40.50%0.2016

30.16%0.6772

59.29%0.3388

48.15%0.5203

Diluted earnings per share

-24.84%0.3338

31.51%0.7049

52.51%0.4441

-8.69%0.536

44.44%0.2912

-13.32%0.587

-40.50%0.2016

30.16%0.6772

59.29%0.3388

51.16%0.5203

Currency Unit

HKD

Accounting Standards

HKAS

Audit Opinions

Unqualified Opinion

Auditor

Guowei Certified Public Accountants Co., Ltd.

	(Q6)Jun 30, 2025	(FY)Dec 31, 2024	(Q6)Jun 30, 2024	(FY)Dec 31, 2023	(Q6)Jun 30, 2023	(FY)Dec 31, 2022	(Q6)Jun 30, 2022	(FY)Dec 31, 2021	(Q6)Jun 30, 2021	(FY)Dec 31, 2020
Turnover	0.99%6.11B	10.59%11.64B	0.96%6.05B	10.12%10.53B	14.90%5.99B	11.22%9.56B	14.15%5.21B	35.34%8.6B	40.26%4.57B	-3.61%6.35B
Operating income	0.99%6.11B	10.59%11.64B	0.96%6.05B	10.12%10.53B	14.90%5.99B	11.22%9.56B	14.15%5.21B	35.34%8.6B	40.26%4.57B	-3.61%6.35B
Cost of sales	-2.09%-2.51B	-22.50%-4.91B	-15.79%-2.46B	-10.93%-4.01B	-8.63%-2.12B	-7.76%-3.61B	-16.66%-1.95B	-44.57%-3.35B	-37.73%-1.67B	9.08%-2.32B
Operating expenses	-2.09%-2.51B	-22.50%-4.91B	-15.79%-2.46B	-10.93%-4.01B	-8.63%-2.12B	-7.76%-3.61B	-16.66%-1.95B	-44.57%-3.35B	-37.73%-1.67B	9.08%-2.32B
Gross profit	0.25%3.6B	3.28%6.74B	-7.16%3.59B	9.62%6.52B	18.66%3.87B	13.42%5.95B	12.70%3.26B	30.04%5.25B	41.77%2.89B	-0.15%4.04B
Selling expenses	-18.88%-1.92B	-26.84%-3.26B	1.57%-1.61B	-11.32%-2.57B	-19.27%-1.64B	3.81%-2.31B	2.94%-1.37B	-28.91%-2.4B	-48.06%-1.41B	16.94%-1.86B
Administrative expenses	-14.11%-691.75M	-10.61%-1.37B	12.89%-606.2M	-13.24%-1.23B	-26.35%-695.89M	-19.83%-1.09B	-28.34%-550.76M	-32.74%-909.62M	-39.62%-429.15M	-12.40%-685.24M
Revaluation surplus	-60.66%174.59M	451.71%648.55M	93.22%443.75M	314.11%117.55M	158.50%229.66M	-111.52%-54.9M	-231.34%-392.56M	75.56%476.5M	5,081.53%298.89M	2,668.46%271.41M
-Changes in the fair value of derivative financial instruments	----	12.71%-27.38M	----	-178.98%-31.37M	----	575.69%39.72M	----	---8.35M	----	----
-Changes in the fair value of financial assets	-60.66%174.59M	353.88%675.93M	93.22%443.75M	257.38%148.92M	158.50%229.66M	-119.52%-94.62M	-231.34%-392.56M	78.64%484.85M	5,081.53%298.89M	2,668.46%271.41M
Impairment and provision	----	22.23%-122.45M	----	-1,072.83%-157.45M	---59.65M	-3,703.12%-13.43M	----	98.02%-353K	----	69.21%-17.81M
-Goodwill impairment	----	-25.39%-49.07M	----	-7.39%-39.14M	----	---36.44M	----	----	----	----
-Other impairment is provision	----	37.98%-73.38M	----	-614.04%-118.32M	---59.65M	6,620.40%23.02M	----	98.02%-353K	----	69.21%-17.81M
Special items of operating profit	147.42%203.58M	324.22%241.73M	131.75%82.28M	-150.96%-107.81M	-409.81%-259.14M	-39.38%211.57M	36.67%83.64M	-9.00%349.02M	-35.97%61.2M	45.47%383.55M
Operating profit	-27.85%1.37B	12.02%2.88B	31.36%1.9B	-4.59%2.57B	40.73%1.45B	-2.41%2.7B	-27.09%1.03B	29.99%2.76B	62.46%1.41B	53.30%2.13B
Financing cost	6.70%-80.35M	12.14%-180.24M	23.94%-86.12M	-49.20%-205.15M	-79.13%-113.23M	-47.90%-137.49M	-167.05%-63.21M	19.46%-92.96M	59.27%-23.67M	21.22%-115.42M
Share of profits of associates	207.95%57.94M	694.69%148.72M	376.26%18.82M	42.89%-25.01M	85.92%-6.81M	-138.46%-43.79M	-308.46%-48.38M	83.71%113.86M	-62.66%23.21M	-46.09%61.98M
Earning before tax	-26.42%1.35B	21.68%2.85B	38.18%1.83B	-6.86%2.34B	44.77%1.33B	-9.65%2.52B	-34.99%915.7M	34.35%2.79B	61.66%1.41B	52.92%2.07B
Tax	28.73%-174.02M	13.92%-386.3M	9.20%-244.18M	-7.19%-448.76M	-23.49%-268.93M	-9.94%-418.64M	-6.60%-217.78M	-30.24%-380.8M	-23.44%-204.3M	-26.85%-292.37M
After-tax profit from continuing operations	-26.07%1.17B	30.10%2.47B	50.24%1.59B	-9.67%1.9B	51.42%1.06B	-12.76%2.1B	-42.04%697.92M	35.02%2.41B	70.62%1.2B	58.26%1.78B
Earning after tax	-26.07%1.17B	30.10%2.47B	50.24%1.59B	-9.67%1.9B	51.42%1.06B	-12.76%2.1B	-42.04%697.92M	35.02%2.41B	70.62%1.2B	58.26%1.78B
Minority profit	-83.70%4.85M	-115.00%-2.32M	8.55%29.76M	-17.99%15.44M	319.55%27.42M	662.74%18.83M	-837.19%-12.49M	121.56%2.47M	113.35%1.69M	55.02%-11.45M
Profit attributable to shareholders	-24.96%1.17B	31.30%2.47B	51.35%1.56B	-9.59%1.88B	44.90%1.03B	-13.45%2.08B	-40.92%710.41M	34.02%2.4B	67.37%1.2B	55.76%1.79B
Basic earnings per share	-24.84%0.3338	31.51%0.7049	52.51%0.4441	-8.69%0.536	44.44%0.2912	-13.32%0.587	-40.50%0.2016	30.16%0.6772	59.29%0.3388	48.15%0.5203
Diluted earnings per share	-24.84%0.3338	31.51%0.7049	52.51%0.4441	-8.69%0.536	44.44%0.2912	-13.32%0.587	-40.50%0.2016	30.16%0.6772	59.29%0.3388	51.16%0.5203
Currency Unit	HKD	HKD	HKD	HKD	HKD	HKD	HKD	HKD	HKD	HKD
Accounting Standards	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS
Audit Opinions	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion
Auditor	--	Guowei Certified Public Accountants Co., Ltd.	--	Guowei Certified Public Accountants Co., Ltd.	--	Guowei Certified Public Accountants Co., Ltd.	--	Guowei Certified Public Accountants Co., Ltd.	--	Guowei Certified Public Accountants Co., Ltd.

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

No. Symbol 5D % Chg

Hong Kong stocks continue to recover! The Hang Seng Index briefly returned to 26,000 points.

Recently, Hong Kong stocks have rebounded from their lows, with the three major indices continuing their upward momentum. The Hang Seng Inde Show More

年頭旺到年尾

Aug 21, 2025 06:11

Are you foolish? What's the point of knowing your mistakes?

牛牛課堂

Sep 12, 2025 17:29

[Opportunity Express] With stock prices soaring, should SMIC "take profits and exit" or "patiently hold on"?